Prognostic scoring systems for myelodysplastic syndromes (<scp>MDS</scp>) in a population‐based setting: a report from the Swedish <scp>MDS</scp> register

Daniel Moreno Berggren, Yasin Folkvaljon, Marie Engvall, +11

British Journal of Haematology

Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study

Helen White, Matthew Salmon, Francesco Albano, +57

Leukemia

Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics

Marie Engvall, Nicola Cahill, Britt-Inger Jonsson, +3

BMC Medical Genomics

Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML

Sylvain Mareschal, Anna Palau, Johan Lindberg, +15

Blood Advances

Clonal haematopoiesis as a risk factor for therapy‐related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo‐(immuno)therapy

Maria Teresa Voso, Tatjana Pandzic, Giulia Falconi, +20

British Journal of Haematology

Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting

Tatjana Pandzic, Claes Ladenvall, Marie Engvall, +5

HemaSphere

Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population‐based study

Daniel Moreno Berggren, Matilda Kjellander, Ellen Backlund, +10

British Journal of Haematology

Familial platelet disorder due to germline exonic deletions in<i>RUNX1</i>: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium

Marie Engvall, Y Karlsson, Ekaterina Kuchinskaya, +9

Leukemia & lymphoma/Leukemia and lymphoma